Insights

Innovative Drug Delivery Lexaria Bioscience’s proprietary DehydraTECH platform enhances bio-absorption and blood-brain barrier penetration, presenting opportunities to partner with pharmaceutical companies looking to improve delivery efficiency for CNS-related therapies.

Strategic Industry Engagement Participation in major industry events such as BIO International and the H.C. Wainwright Global Investment Conference indicates active outreach to potential partners and investors, opening avenues for collaboration and funding opportunities.

Robust Intellectual Property With a strong portfolio of patents and pending IP worldwide, Lexaria offers a defensible technology platform that can be attractive for licensing agreements, joint ventures, or corporate licensing deals in the biotech sector.

Growing Investment Interest Recent $2 million funding rounds and strategic events signal investor confidence, creating potential for co-investment opportunities or strategic alliances aimed at accelerating product development and commercialization.

Leadership & Expansion New executive appointments such as the Chief Medical and Financial Officers signal active leadership and potential organizational growth, enhancing credibility when engaging with larger pharma and distribution partners seeking innovative drug delivery solutions.

Lexaria Bioscience Tech Stack

Lexaria Bioscience uses 8 technology products and services including Facebook Pixel, Matomo, JSON-LD, and more. Explore Lexaria Bioscience's tech stack below.

Facebook Pixel

Analytics

Matomo

Analytics

JSON-LD

Javascript Frameworks

Mailcheck

Javascript Libraries

Modernizr

Javascript Libraries

Yoast SEO

Search Engines

MailChimp for WordPress

Web Platform Extensions

Facebook

Widgets

Lexaria Bioscience Email Formats	Example	Percentage
FLast@lexariabioscience.com	JDoe@lexariabioscience.com	50%
FLast@lexariabioscience.com	JDoe@lexariabioscience.com	50%

Lexaria Bioscience Email Formats

Example

Percentage

FLast@lexariabioscience.com

JDoe@lexariabioscience.com

50%

FLast@lexariabioscience.com

JDoe@lexariabioscience.com

50%

Frequently Asked Questions

Where is Lexaria Bioscience's headquarters located?

Lexaria Bioscience's main headquarters is located at Kelowna, British Columbia v1x 2p7 Canada. The company has employees across 1 continents, including North America.

What is Lexaria Bioscience's official website and social media links?

Lexaria Bioscience's official website is lexariabioscience.com and has social profiles on LinkedIn Crunchbase.

What is Lexaria Bioscience's SIC code NAICS code?

Lexaria Bioscience's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Lexaria Bioscience have currently?

As of February 2026, Lexaria Bioscience has approximately 10 employees across 1 continents, including North America. Key team members include Chief Executive Officer | Bod Member: R. C.Chief Financial Officer: G. D.President And Head Of Research: J. D.. Explore Lexaria Bioscience's employee directory with LeadIQ.

What industry does Lexaria Bioscience belong to?

Lexaria Bioscience operates in the Biotechnology Research industry.

What technology does Lexaria Bioscience use?

Lexaria Bioscience's tech stack includes Facebook PixelMatomoJSON-LDMailcheckModernizrYoast SEOMailChimp for WordPressFacebook.

What is Lexaria Bioscience's email format?

Lexaria Bioscience's email format typically follows the pattern of FLast@lexariabioscience.com. Find more Lexaria Bioscience email formats with LeadIQ.

How much funding has Lexaria Bioscience raised to date?

As of February 2026, Lexaria Bioscience has raised $1.4M in funding. The last funding round occurred on Apr 25, 2025 for $1.4M.

Lexaria Bioscience

Q: How many employees does Lexaria Bioscience have currently?

Lexaria Bioscience has approximately 10 employees.

Q: What technology does Lexaria Bioscience use?

Lexaria Bioscience's tech stack includes Yoast SEO, Mailcheck, Facebook Pixel, jQuery, Shopify.

Biotechnology ResearchBritish Columbia, Canada2-10 Employees

DehydraTECH™ is Lexaria's patented drug delivery formulation and processing platform technology which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio and many patents pending worldwide.  For more information, please visit www.lexariabioscience.com.

Insights

Similar companies to Lexaria Bioscience

MediPharm Labs